Successful rituximab treatment of severe pemphigus vulgaris resistant to multiple immunosuppressants.
Wenzel
Joerg
J
Bauer
Ralf
R
Bieber
Thomas
T
Tüting
Thomas
T
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001365:Axilla; D001415:Back; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008875:Middle Aged; D010392:Pemphigus / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D000069283:Rituximab; D012720:Severity of Illness Index; D013909:Thorax
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab